Mycobacteria are characterized by their impermeable outer membrane, which is rich in mycolic acids 1 . To transport substrates across this complex cell envelope, mycobacteria rely on type VII (also known as ESX) secretion systems 2 . In Mycobacterium tuberculosis, these ESX systems are essential for growth and full virulence and therefore represent an attractive target for anti-tuberculosis drugs 3 . However, the molecular details underlying type VII secretion are largely unknown, due to a lack of structural information. Here, we report the molecular architecture of the ESX-5 membrane complex from Mycobacterium xenopi determined at 13 Å resolution by electron microscopy. The four core proteins of the ESX-5 complex (EccB 5 , EccC 5 , EccD 5 and EccE 5 ) assemble with equimolar stoichiometry into an oligomeric assembly that displays six-fold symmetry. This membrane-associated complex seems to be embedded exclusively in the inner membrane, which indicates that additional components are required to translocate substrates across the mycobacterial outer membrane. Furthermore, the extended cytosolic domains of the EccC ATPase, which interact with secretion effectors, are highly flexible, suggesting an as yet unseen mode of substrate interaction. Comparison of our results with known structures of other bacterial secretion systems demonstrates that the architecture of type VII secretion system is fundamentally different, suggesting an alternative secretion mechanism.
During the past decade, it has become apparent that the type VII secretion system (T7SS) is essential for mycobacterial virulence and physiology 4 . The first T7SS to be identified was the 6 kDa early secretory antigenic target (ESAT-6) protein family secretion (ESX)-1 system of the human pathogen Mycobacterium tuberculosis [5] [6] [7] . Four other paralogous and highly conserved ESX systems have since been described in mycobacteria, and are termed ESX-2 to ESX-5. Each ESX system has a defined role within the bacterial cell that is mediated by a diverse repertoire of secreted effector proteins, with each system exclusively secreting its cognate effectors 4 . Intriguingly, unlike most bacterial secretion systems, such as the type III secretion system (T3SS), the ESX systems mediate the export of folded substrates across the diderm mycobacterial cell envelope, indicating a novel mode of protein transport.
The ESX-5 system is found only in slow-growing species of mycobacteria, which includes most pathogenic species. In addition to being crucial for nutrient uptake 8 , the ESX-5 system secretes two large families of effector proteins-the Pro-Glu (PE) and Pro-Pro-Glu (PPE) proteins-several of which are required for immune evasion and virulence 9 . The ESX-5 membrane complex, which can be stably purified has an estimated size of 1.5 MDa and comprises the core proteins EccB 5 , EccC 5 , EccD 5 and EccE 5 (ref. 10) . Whether the four core components are sufficient to span the entire diderm cell envelope of mycobacteria is not clear 1, 11 . In addition, the structural and functional roles of the core components within the complex have not been explored, with the exception of EccC 5 (ref. 12) . As a member of the FtsK/SpoIIIE ATPase family, EccC 5 is presumed to be the coupling component that mediates effector protein recognition and energizes translocation through the channel 13 . Elucidating the architecture of the ESX-5 core complex is crucial to furthering our understanding of the mechanism of T7SS-mediated protein transport across the complex mycobacterial cell envelope.
The absence of an endogenous ESX-5 system in the avirulent and fast-growing species Mycobacterium smegmatis offers a unique opportunity to investigate the functionality and structure of this system 2 . After screening various mycobacterial species, the ESX-5 system from the mildly thermophilic and slow-growing species Mycobacterium xenopi was selected for structural analysis because of its high expression levels and superior stability. To recombinantly express and purify this complex, the esx-5 locus from M. xenopi was cloned into a mycobacterial expression vector and modified to produce EccC 5 with a streptavidin tag (Strep-tag II) at its carboxy terminus ( Supplementary Fig. 1a ). Secretion analysis of the Streptagged ESX-5 system in M. smegmatis indicated that this system is functional and able to export EsxN, which is encoded by the introduced esx-5 locus, as well as the heterologously expressed PPE18 from Mycobacterium marinum 14 into the culture filtrate (Fig. 1a) . Previous data suggested that secreted effector proteins have a potential role in initiating the assembly of purified EccC (ref. 12). We investigated whether substrates are similarly involved in complex assembly by generating an expression construct devoid of the six secreted substrates, including Esx, PE and PPE proteins, encoded within the esx-5 locus (Supplementary Fig. 1a) . Notably, M. smegmatis lacks endogenous ESX-5 substrates and, so far, no redundancy in substrate secretion between different ESX systems has been observed. Using blue native polyacrylamide gel electrophoresis (BN-PAGE) followed by immunoblot analysis of isolated membranes, we found that biogenesis of the membrane complex occurs in the absence of these proteins, thus establishing that the ESX-5 complex assembles in a substrate-independent manner, in contrast to what has previously been reported for purified EccC (ref. 12) (Supplementary Fig. 1b) .
To obtain insight into the architecture of the ESX-5 secretion channel, we solubilized membrane preparations with the detergent n-dodecyl β-D-maltoside (DDM) and purified the complex by affinity purification and size exclusion chromatography (SEC) (Supplementary Fig. 2a ). The presence of the four core components EccB 5 , EccC 5 , EccD 5 and EccE 5 was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and mass spectrometry (Fig. 1b) . BN-PAGE analysis of the ESX-5 EccBC strep DE complex, hereafter simply referred to as the ESX-5 complex, shows a band at ∼1.5 MDa (Supplementary Fig. 2b) , consistent with previous studies 15 .
Electron microscopy (EM) was used to visualize the purified complexes. Visual inspection of electron micrographs of negatively stained DDM-solubilized sample showed the presence of large particles in multiple orientations. We also observed smaller particles, which may represent subcomplexes also seen by BN-PAGE ( Supplementary Fig. 2b ). To improve sample stability, the DDM in the affinity-purified samples was exchanged to the surfactant amphipol A8-35 before SEC purification. This considerably reduces the presence of subcomplexes in the sample and thus improved the quality of the EM images obtained (Fig. 1c and Supplementary  Fig. 2b-d) . The inherent adenosine 5′-triphosphate (ATP) hydrolysing activity and hence the functional integrity of the purified complex was established using radioactive ATP (γ-32 P) (Fig. 1d ). In addition, determination of the relative abundance of each component by mass spectrometry indicated that the complex contains all four components in equimolar amounts ( Fig. 1e and Supplementary Table 1 ). Interesting features observed in the raw images were tail-like extensions, projecting away from the compact globular complex (Fig. 1f ) . The structure of these ∼14 nm elongated projections is reminiscent of the EM 'beads-on-a-string' structure of the Thermomonospora curvata EccC (ref. 12).
Single-particle analysis and a reference-free two-dimensional class averaging of 1,418 particles, followed by an initial three-dimensional reconstruction of the complex without symmetry constraints, revealed a hexameric arrangement around the central axis (Fig. 1g,h,  Supplementary Fig. 3a ,b and Supplementary Table 2 ). Further refinement applying six-fold symmetry resulted in a map at 13 Å resolution that shows a compact, globular macromolecular assembly of ∼28 × 16 nm ( Fig. 2a and Supplementary Fig. 3c ). Combining our observations on ESX-5 symmetry and our mass spectrometry data led to a 24-subunit (that is, 6 × 4) ESX-5 complex with a mass of 1.8 MDa. The dimensions of the complex indicate that the ESX-5 core complex is embedded in the inner membrane, rather than spanning both cell membranes. A central pore extends through the complex, with a diameter of ∼5 nm (Fig. 2b) . Such pore dimensions are sufficient to allow the passage of folded, dimeric T7SS effectors such as the Esx proteins, which have an estimated width of 2 nm (ref. 16 ). The long extensions observed in the EM images of individual single particles are, however, not visible in the three-dimensional reconstruction, probably due to the averaging effects of multiple flexible states. /I(0)) (cyan). The scattering vector is indicated by s. R g is the radius of gyration, I(0) is the forward scattering intensity and I(s) is the experimental scattering intensity. Error bars indicate the standard deviation of the scattering intensity. For reference, typical profiles for a folded, globular particle (dashed line) and an unfolded particle (black line) are included. d, Flexibility analysis using EOM shows the R g distribution for a random pool (shaded grey) of 10,000 structures, where the bimodal population of selected ensembles (black bars) best fit the scattering data. The results suggest that the DUF domain occupies a continuum of populations in solution ranging from compact to rather extended conformations. e, Segmentation analysis of the EM volume highlighting the position of EccB 5 (orange and yellow, alternating) according to the consensus of both docking approaches within the complex (white) in side and top view. f, A side-view cross-section of the map shows density on the periplasmic side of the complex that cannot be attributed to To confirm that these elongated structures are indeed the integral membrane ATPase, we performed on-the-grid gold labelling of Strep-tagged EccC 5 on individual isolated complexes (Fig. 3a) . EccC 5 comprises an N-terminal double-pass transmembrane domain (TMD), an unclassified domain of unknown function (DUF) and three cytosolic ATPase domains (A1, A2, A3) 4, 12 . To investigate the flexibility of the cytosolic segment of EccC 5 in solution, a truncated version of EccC 5 lacking the TMD (EccC 5 Δ99 ) was generated. SEC coupled with multi-angle light scattering revealed that EccC 5 Δ99 exists primarily as a monomer in solution ( Supplementary Fig. 4a ). Small-angle X-ray scattering (SAXS) data collected on monomeric EccC 5 Δ99 yielded parameters consistent with a solution of elongated monomeric particles ( Supplementary Fig. 4b and Supplementary Table 3 ). Furthermore, these data suggest that these elongated particles are flexible (Fig. 3c) . To model this conformational flexibility, ensemble optimization methods (EOMs) were used in combination with an EccC 5 homology model. Three independent model ensembles were tested to probe the origin of flexibility within EccC 5 Δ99 (Supplementary Fig. 4c ). Optimized ensembles allowing flexibility only in the DUF domain, while treating the three ATPase domains as a single rigid body (model ensemble 3), accurately described the scattering data ( Supplementary Fig. 4c ). This analysis indicates that the observed flexibility largely arising from the DUF domain enables EccC 5 to adopt multiple conformations ranging from extended to more compact (Fig. 3d) .
Once we identified the flexible cytoplasmic extensions as EccC 5 , we were able to orientate the EM map in the inner membrane. Next, we aimed to pinpoint the location of the predominantly periplasmic component, EccB 5 18 . Docking of a hexameric model of EccB 5 gave a convincing fit to the map, placing the majority of EccB 5 at the core of the ESX-5 complex ( Supplementary Fig. 5a ). Alternative docking positions for EccB 5 were investigated following segmentation analysis of the EM map 19 , which revealed a density consistent with the EccB 5 homology model (Supplementary Fig. 5b ). Both docking approaches position the N-terminal domain of EccB 5 at the periplasmic face of the complex, forming a collar-like structure around the pore (Fig. 3e) .
On the periplasmic side of the complex, additional density was observed that could not be attributed to EccB 5 using either model (Fig. 3f ) . As topology predictions indicate that both EccC 5 and EccD 5 have minimal mass protruding into the periplasm 15 , we hypothesized that the unaccounted density arises from EccE 5 . This would agree with the previous observation that EccE 5 is a peripheral component of the complex, as it is not present in all ESX systems. ESX-1, ESX-2, ESX-3 and ESX-5, but not ESX-4, have EccE homologues that share a relative low sequence identity (19-24% in M. tuberculosis) and are particularly sensitive to protease digestion 15 . Bioinformatic predictions of the membrane topology of the different EccE proteins are not consistent, but frequently indicate that the bulk of EccE 5 is in the cytosol 20 . To identify the location of EccE 5 within the complex, we generated an expression construct in which EccE 5 was modified to include a C-terminal hexahistidine tag. Addition of the tag did not have ; T3SS from Salmonella thyphimurium (EMD-1875) 40 ; T4SS from E. coli (EMD-2567) 41 ; and T6SS from E. coli (EMD-2927) 42 . Top, side and bottom views are shown for comparison, demonstrating the overall symmetry of the secretion system. The positions on the inner membrane (IM), outer membrane (OM), mycobacterial outer membrane (MOM) and periplasm (PP) are indicated. b, Summary of the characteristics of each of the displayed secretion systems including the molecular mass (MDa), the number of subunits and overall symmetry. The method used to determine the different models and the achieved resolution is indicated: NS, negative-stain EM; Cryo, cryo-electron microscopy.
any effect on complex formation or stability, as judged from the appearance of the ESX-5
EccE-His complex visualized by negative staining ( Supplementary Fig. 6a-c) . However, the functionality of this construct was not tested further. Using gold labelling, we found that EccE 5 seems to be located at the periphery of ESX-5 with its C-terminal domain residing in the periplasm (Fig. 3b) . This is further supported by the observation that EccE 5 forms disulfide bonds, which are unlikely to occur in the reducing environment of the cytosol (Supplementary Fig. 7) .
Because Supplementary Fig. 8a-c Supplementary Fig. 8d-f) . Class averages of the ESX-5
ΔEccE similarly show hexameric symmetry around a central pore ( Supplementary  Fig. 8g ). Comparative analysis of the class averages of ESX-5 versus ESX-5
ΔEccE shows the missing density at the periphery of the complex in the latter ( Supplementary Fig. 8h,i) , which also strengthens the periplasmic localization of the bulk of EccE 5 .
Given that most ESX systems are presumably composed of the same set of conserved core components 4 , our structural model of the ESX-5 secretion apparatus from M. xenopi may serve as a template for mycobacterial T7SSs in general (Fig. 3g) . Direct comparison of our T7SS structure with those from other secretion systems reveals that it is fundamentally different in terms of both overall dimensions and symmetry (Fig. 4) . Whereas T1SSs, T3SSs, T4SSs and T6SSs span the inner and outer membrane of Gram-negative bacteria, the overall dimensions of the T7SS molecular assembly confine its role to an inner membrane secretion apparatus 11 . This raises the question as to how the folded substrates are secreted out of the cell after translocation through the T7SS inner membrane complex. Recently, a role of EspC, a specific substrate of the ESX-1 system, in outer membrane translocation of ESX-1 substrates has been proposed, as it localizes to the mycobacterial cell envelope and forms needle-like structures when overexpressed in Escherichia coli 21 . As the ESX-5 system lacks an EspC homologue and, in contrast to ESX-5, EspC is not essential for growth, we do not foresee that EspC-like needles are involved in ESX-5 mediated transport. Nevertheless, the possibility remains that the outer membrane conduit for the ESX-5 system is formed by another (ESX-5) substrate. A striking feature is the flexibility of EccC 5 at the cytosolic face of the ESX-5 complex. Different from the equivalent ATPase in T4SS, which forms two rigid barrel-like structures 22 , EccC 5 adopts an elongated, flexible tentacle-like configuration. Moreover, the six-fold symmetry we observed in the ESX-5 complex may provide insights into the overall structural requirements of additional and as yet unidentified components involved in subsequent secretion steps. Our data provide novel insights into the mechanism of substrate recognition and translocation through the ESX-5 inner membrane complex. The obtained structure of the ESX-5 complex is a strong basis for future research aimed at identifying and characterizing the interactions required for the complete T7SS assembly, such as MycP, needed for complex stability 23 , as well as the components necessary to bridge the periplasm and the outer membrane.
Methods
Molecular biology. Polymerase chain reaction (PCR) was performed using Phusion DNA polymerase (New England Biolabs). For cloning, E. coli DH5α was used. The pMV-eccBC 5mm containing a Strep-tag II coding sequence 23 was modified by PCR amplification to contain the NsiI restriction sites upstream of eccB 5 and the AflII site between the Strep-tag II sequence and the HindIII restriction site. The resulting plasmid and the previously described pMV plasmid 10 carrying the complete esx-5 locus of M. tuberculosis were further modified by (1) replacing the hygromycin resistance cassette by a streptomycin resistance gene; (2) introducing the pAL5000 origin of replication 24 by homologous recombination via a commercial kit (Clontech In-Fusion); and (3) deletion of the Hsp60 promoter. The eccBC 5mx coding region was amplified by PCR from M. xenopi RIVM700367 chromosomal DNA to introduce the NsiI and DraI restriction sites. This PCR fragment was cloned into the modified plasmid by replacing the eccBC 5mm sequence. The MXEN9349-eccA 5 coding regions were amplified by PCR from M. xenopi RIVM700367 chromosomal DNA to introduce the AflII and HindIII restriction sites and ligated in the intermediate pMV plasmid to generate the pMV-ESX-5. The pMV-ESX-5 was further digested with AflII and SnaBI and then re-ligated to result in pMV-ESX-5
Δsubst . pMV-ESX-5 ΔEccE resulted from the restriction of pMV-ESX-5 with MluI and HindIII and subsequent re-ligation. Similarly, pMV-ESX-5
EccE-His was derived from pMV-ESX-5 by introducing a hexahistidine-tag sequence downstream of eccE 5 using the restriction site MluI. The eccC 5 gene was amplified by PCR to include the cytoplasmic domain (residues 99-1392) and inserted into the pMyNT vector using SliCE methods 25 , generating pMyNT-EccC 5
Δ99
.
Secretion analysis. ESX-5 constructs were expressed in M. smegmatis mc 2 155, and the functionality of the reconstituted system was analysed by culturing bacteria to mid-logarithmic phase and separating the whole cells from the supernatant by centrifugation and filtration. pSMT3-PE31/PPE18-HA (ref. 14) , carrying pe31 and ppe18, followed by an HA sequence from M. marinum, was also introduced to assess secretion of the PPE18 of M. marinum. Subsequently, samples were run on SDS-PAGE for immunoblotting with sera against the HA-tag, EsxN, EccB 5 and GroEL2 (ref. 15 ). Anti-EsxN, anti-EccB 5 and anti-GroEL2 have been described previously 10 , and the anti-HA antibody was purchased from Covance/BioLegend (cat. no. MMS-101P).
Protein overexpression and purification. Equivalent purification protocols were followed for the production of the ESX-5 variants discussed in this study (ESX-5, ESX-5
EccE-His and ESX-5
ΔEccE
). M. smegmatis mc 2 155 was transformed with the relevant plasmid and cultured in Middlebrook 7H9 medium (BD Bioscience) supplemented with 0.2% (vol/vol) glycerol, 10% albumin-dextrose saline (5% (wt/vol) BSA, 2% (wt/vol) glucose, 342 mM NaCl) and 0.05% (vol/vol) Tween-80 at 120 r.p.m. At an optical density at 600 nm (OD 600 ) of 1.5, cells were pelleted by centrifugation and suspended in buffer A (20 mM Tris pH 8.0, 300 mM NaCl 10% (vol/vol) glycerol) with EDTA-free protease inhibitors (Roche). Cells were lysed by high-pressure emulsification, and unbroken cells were removed by centrifugation (12 min at 10,000g). Membrane fractions were isolated from the supernatant by ultracentrifugation (1 h at 98,000g). Membranes were resuspended in buffer A and solubilized using 0.25% DDM for 1 h at 4°C. Insoluble material was removed by ultracentrifugation (30 min at 98,000g) and the clarified lysate was incubated with StrepTactin beads (IBA). Following a wash step with buffer A, the complex eluted with buffer A supplemented with 10 mM desthiobiotin (IBA). When exchanging DDM for amphipol A8-35, A8-35 was added in a 5:1 ratio with protein and incubated with BioBeads (Bio-Rad) overnight. The sample was purified further by SEC using a Superose 6 10/300GL column (GE Healthcare) and analysed by SDS-PAGE and BN-PAGE. Samples were further analysed by immunoblotting using antiserum against EccB 5 In-gel and in-solution digestion. For in-solution processing (replicates 1-3), all reagents were prepared in 50 mM HEPES (pH 8.5). Cysteines were reduced using dithiothreitol (56°C, 30 min, 10 mM). Samples were cooled to 24°C and alkylated with iodacetamide (room temperature, in the dark, 30 min, 10 mM). Subsequently, the samples were prepared for liquid chromatography tandem mass spectrometry (LC-MS/MS) using the SP3 protocol 27 , digested with trypsin, and the peptides were cleaned up using OASIS HLB µElution Plate (Waters).
For in-gel processing, the sample (replicate 4) was separated in a native gel and stained with Coomassie. The bands corresponding to the complex were cut from the gel and subjected to in-gel digestion with trypsin 28 . Subsequently, peptides were extracted from the gel pieces. Samples were sonicated for 15 min, centrifuged, and the supernatant was removed and placed in a clean tube. A solution of 50:50 water: acetonitrile, 1% formic acid (2× the volume of the gel pieces) was added, and the samples were again sonicated for 15 min, centrifuged, and the supernatant pooled with the first extract. The pooled supernatants were then dried down with the speed vacuum centrifuge. The samples were dissolved in 10 µl reconstitution buffer (96:4 water:acetonitrile, 0.1% formic acid) and analysed by LC-MS/MS. LC-MS/MS. Replicates 1-3 were analysed on a Q Exactive Plus instrument (Thermo Scientific). Peptides were separated using the UltiMate 3000 RSLC nano LC system (Dionex) fitted with a trapping cartridge (µ-Precolumn C18 PepMap 100, 5 µm, 300 µm ID × 5 mm, 100 Å) and an analytical column (Acclaim PepMap 100, 75 µm × 50 cm C 18 , 3 µm, 100 Å) over a 70 min gradient and online injected into the mass spectrometer. The resolution of MS scans was set to 70,000. The filling time was set to a maximum of 100 ms with a target of 3 × 10 6 ions. Acquisition was performed in data-dependent mode (DDA). The resolution of MS2 scans was set to 17,500, with a fill time of 50 ms and a target of 1 × 10 5 ions. Normalized higher-energy collisional dissociation was set to 26.
Replicate 4 was analysed on an Orbitrap Velos instrument (Thermo Scientific). Peptides were separated using the nanoAcquity ultra performance liquid chromatography (UPLC) system (Waters) fitted with a trapping column (nanoAcquity Symmetry C18, 5 µm, 180 µm × 20 mm) and an analytical column (nanoAcquity BEH C18, 1.7 µm, 75 µm × 250 mm) over a 35 min gradient and online injected into the mass spectrometer. The Orbitrap Velos mass spectrometer was operated with a data-dependent top 15 method. MS spectra were acquired using a resolution of 30,000 and an ion target of 1.0 × 10 6 . Collision-induced dissociation (CID) was performed in the linear trap quadrupole (LTQ) using a normalized collision energy of 40%, and an ion target of 3.0 × 10 4 . To improve the mass accuracy, a lock mass correction using the ion (m/z 445.12003) was applied.
Data processing. The raw mass spectrometry data were processed with MaxQuant (v1.5.2.8) 29 and searched against a database containing the sequences of proteins of the complex as well as common contaminants. The data were searched with the following modifications: Carbamidomethyl (C) (fixed modification), Acetyl (N-term) and Oxidation (M) (variable modifications). The mass error tolerance for the full scan MS spectra was set to 20 ppm and for the MS/MS spectra to 0.5 Da. A maximum of two missed cleavages was allowed. For protein identification a minimum of two unique peptides with a peptide length of at least seven amino acids and a false discovery rate below 0.01 were required on the peptide and protein level. Quantification was performed using iBAQ values 30 calculated as the sum of the intensities of the identified peptides and divided by the number of observable peptides of a protein. Relative protein concentrations were calculated for each replicate by dividing the iBAQ value of each subunit by the average intensity-based absolute protein quantification (iBAQ) value of the four subunits. The average relative protein concentration was calculated as the average of the relative protein concentration for each subunit over the four replicates. The standard error of the mean was calculated for each average relative protein concentration (Supplementary Table 3 ).
SEC coupled with multi-angle light scattering. EccC 5 Δ99 was concentrated to 2.5 mg ml −1 in 20 mM Tris pH 8.0, 200 mM NaCl, 5% (vol/vol) glycerol. SEC was performed at room temperature using a Superdex 200 10/300GL column. Separated sample components were analysed in-line with a modular triple detector array (Viscotek TDA 305, Malvern Instruments) to determine right-angle light scattering (RALS), refractive index (RI) and UV-vis (UV). Data were processed using Omnisec software (Malvern). The molecular weight of the species eluting from the SEC column (M w RALS ) was assessed using correlated concentration measurements derived from baseline-corrected RI in combination with baseline-corrected RALS intensities calibrated against a bovine serum albumin narrow standard (monomeric peak).
Homology modelling and docking. Homology models of the M. xenopi EccB 5 and EccC 5 were generated using MODELER v9.17 (ref. 17) using default settings. The homology model of the C-terminal part of M. xenopi EccC 5 (residues 429-1386) was divided into three ATPase domains, A1 (residues 431-712), A2 (residues 826-1123) and A3 (residues 1135-1389), based on the T. curvata EccC structure (PDB code 4NH0). The hexamer of the M. xenopi EccB 5 was generated using SymmDock 31 by applying a six-fold symmetry. Models were docked into the EM map or segmented EM volumes using Chimera 32 .
SAXS. Synchrotron SAXS data were collected at EMBL P12 beamline (DESY, Hamburg) and recorded at 10°C using a PILATUS 1M pixel detector (DECTRIS) at a sample-detector distance of 2.7 m and a wavelength of 1.24 Å (Supplementary Data Table 1 ). Purified EccC 5 Δ99 was measured in a concentration range from 0.1 to 7 mg ml −1 from fractions corresponding to the monomeric species. For calculation of the forward scattering intensity I(0) and the radius of gyration (R g ), the Guinier approximation implemented in PRIMUS 33 was used. The pair-distance distribution function P(r) was evaluated with GNOM 34 and the maximum particle dimension (D max ) as well as R g were estimated consecutively. Flexibility was assessed with the Ensemble Optimization Method (EOM) program 35 . The model was divided into rigid bodies corresponding to ATPase domains A1, A2 and A3. EOM was performed using three independent runs describing the potential flexibility of EccC 5
Δ99
. During run 1, A1, A2 and A3 were treated as single independent rigid bodies; in run 2, A2 and A3 were combined into one rigid body; in run 3 A1, A2 and A3 were fixed as one rigid body. In all runs, the DUF domain was treated as a flexible entity. The fit of the best ensemble of conformations, selected by EOM, was guided by the χ 2 criterion:
where I exp(s j ) is the experimental scattering, K is the number of experimental points, σ(s j ) are standard deviations and c is a scaling factor 36 .
ATPase assays. ) and incubating at 37°C for 1 h, to a total reaction volume of 10 µl. The control reaction was conducted in parallel without the addition of ESX-5 complex. The reaction was stopped by the addition of 20 mM EDTA and the reaction products were isolated by phenol:chloroform extraction and loaded onto a PEI-cellulose TLC plate. The TLC plate was run in 0.5 M LiCl, 1 M formic acid, and plates were allowed to dry before imaging. Signals were detected following exposure to an image plate (Fujifilm) and analysed using a Phosphor-Imager (Fujifilm). Assays were performed in triplicate.
Disulfide bond analysis. Isolated M. smegmatis membranes containing ESX-5 membrane complexes from either M. xenopi or M. tuberculosis were incubated in buffer A (20 mM Tris pH 8.0, 300 mM NaCl, 10% (vol/vol) glycerol) including 0 or 10 mM DTT for 10 min at 37°C. Samples were subsequently analysed by SDS-PAGE and immunoblotting using SDS sample buffer devoid of reducing agent. The antisera used against EccB 5 and EccE 5 have been described previously 10 .
EM and image processing. EM samples were prepared by applying a protein solution (3 µl) on previously glow-discharged carbon-coated copper grids and negatively stained with 2% uranyl acetate. For gold labelling sample screening of the gold-labelled ESX-5 EccE-His complex and the ESX-5
ΔEccE
, grids were imaged with a Tecnai Morgani electron microscope operating at 80 kV at a defocus of ∼2 µm and at a calibrated magnification of ×24,194, resulting in a pixel size of 3.72 Å on the specimen. For the single-particle analysis, grids were imaged under low-dose conditions with a Tecnai T20 electron microscope operating at 200 kV. Data were collected on a FEI BM EAGLE camera, with a step size of 15 µm, a defocus range of 1.4-5.0 µm and at a nominal magnification of ×50,000, resulting in a pixel size of 2.18 Å on the specimen. For the ESX-5 complex, a total of 65 micrographs were collected and, for each of these, a second micrograph at 50°tilt was acquired. A total of 1,418 particles were boxed out manually using 'e2boxer.py' in the EMAN2 software package 37 using a box size of 320 pixels. For the the ESX-5
ΔEccE sample, 50 micrographs were collected using the same conditions and a total of 684 particles were selected using a box size of 180 pixels.
A first step of two-dimensional reference-free class averaging showed the particles to have no preferred orientation on the carbon layer and revealed hexameric classes. To test for symmetry, rotational cross-correlations were calculated from reference-free aligned classes over 360°in 1°steps (IMAGIC-5, Images Science Software). The initial three-dimensional model was obtained using the EMAN2 initial-model-generation program e2initialmodel.py, without applying symmetry. This process yielded a six-fold shaped map. A series of independent three-dimensional refinement rounds were performed using different starting three-dimensional references obtained in the previous step of initial model generation, and these retained the six-fold symmetry topology and overall EM map. Based on these findings, in the final refinement steps, a six-fold symmetry constraint was applied. During the three-dimensional refinement rounds the best self-consistent subset of particles was obtained by keeping the best 70% of the particles from each reference-based class average based on mutual similarity among T7SS particles. The final resolution was estimated from two independent reconstructions by the gold-standard Fourier shell correlation (FSC) criteria of 0.143 using the 'e2refine_easy.py' tool of EMAN2. The final map was corrected for the contrast transfer function amplitude and Wiener-filtered based on the FSC curve. Map segmentation was performed using Segger software 19 . The handedness of the map was analysed by tilt-pair validation using the 'e2tiltvalidate.py' program in EMAN2 (ref.
38). For the ESX-5
ΔEccE sample, 50 micrographs were collected with a Tecnai Morgani electron microscope operating at 80 kV at a defocus range of ∼1-4 µm and at a calibrated magnification of ×24,194, resulting in a pixel size of 3.72 Å on the specimen. A total of 684 particles were boxed out manually using 'e2boxer.py' with a box size of 180 pixels and subjected to two-dimensional reference-free class averaging.
Gold labelling. Complex components were labelled using 5 nm streptavidin (Nanoncs) for the ESX-5 complex against the EccC 5 -Strep or Ni-NTA (Nanoprobes) nanogold beads for the ESX-5
EccE-His complex. Purified complexes were incubated for 1 h with varying concentrations of gold beads diluted in SEC buffer, applied directly onto a glow-discharged carbon-coated grid and stained as described above.
Data availability. The EM data of the ESX-5 membrane complex that support the findings of this study have been deposited in the Electron Microscopy Data Bank under accession code EMD-3596. SAXS data are available from SASBDB (www.sasbdb.org) under accession code SASDBE7.
